Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Integrating Viral Vectors
1.2.3 Non-Integrating Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Gene Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Metabolic Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Muscular Diseases
1.3.5 Hematologic Diseases
1.3.6 Ophthalmologic Diseases
1.3.7 Infectious Diseases
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Gene Therapy Market Perspective (2018-2029)
2.2 Viral Gene Therapy Growth Trends by Region
2.2.1 Global Viral Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Viral Gene Therapy Historic Market Size by Region (2018-2024)
2.2.3 Viral Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Viral Gene Therapy Market Dynamics
2.3.1 Viral Gene Therapy Industry Trends
2.3.2 Viral Gene Therapy Market Drivers
2.3.3 Viral Gene Therapy Market Challenges
2.3.4 Viral Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Gene Therapy Players by Revenue
3.1.1 Global Top Viral Gene Therapy Players by Revenue (2018-2024)
3.1.2 Global Viral Gene Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Gene Therapy Revenue
3.4 Global Viral Gene Therapy Market Concentration Ratio
3.4.1 Global Viral Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Gene Therapy Revenue in 2022
3.5 Viral Gene Therapy Key Players Head office and Area Served
3.6 Key Players Viral Gene Therapy Product Solution and Service
3.7 Date of Enter into Viral Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Gene Therapy Breakdown Data by Type
4.1 Global Viral Gene Therapy Historic Market Size by Type (2018-2024)
4.2 Global Viral Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Viral Gene Therapy Breakdown Data by Application
5.1 Global Viral Gene Therapy Historic Market Size by Application (2018-2024)
5.2 Global Viral Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Viral Gene Therapy Market Size (2018-2029)
6.2 North America Viral Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Viral Gene Therapy Market Size by Country (2018-2024)
6.4 North America Viral Gene Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Gene Therapy Market Size (2018-2029)
7.2 Europe Viral Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Viral Gene Therapy Market Size by Country (2018-2024)
7.4 Europe Viral Gene Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Gene Therapy Market Size (2018-2029)
8.2 Asia-Pacific Viral Gene Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Viral Gene Therapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Viral Gene Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Gene Therapy Market Size (2018-2029)
9.2 Latin America Viral Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Viral Gene Therapy Market Size by Country (2018-2024)
9.4 Latin America Viral Gene Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Gene Therapy Market Size (2018-2029)
10.2 Middle East & Africa Viral Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Viral Gene Therapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Viral Gene Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Viral Gene Therapy Introduction
11.1.4 Lonza Revenue in Viral Gene Therapy Business (2018-2024)
11.1.5 Lonza Recent Development
11.2 Biogen
11.2.1 Biogen Company Detail
11.2.2 Biogen Business Overview
11.2.3 Biogen Viral Gene Therapy Introduction
11.2.4 Biogen Revenue in Viral Gene Therapy Business (2018-2024)
11.2.5 Biogen Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent Viral Gene Therapy Introduction
11.3.4 Catalent Revenue in Viral Gene Therapy Business (2018-2024)
11.3.5 Catalent Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Detail
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Viral Gene Therapy Introduction
11.4.4 Gilead Sciences Revenue in Viral Gene Therapy Business (2018-2024)
11.4.5 Gilead Sciences Recent Development
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Detail
11.5.2 Sarepta Therapeutics Business Overview
11.5.3 Sarepta Therapeutics Viral Gene Therapy Introduction
11.5.4 Sarepta Therapeutics Revenue in Viral Gene Therapy Business (2018-2024)
11.5.5 Sarepta Therapeutics Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Viral Gene Therapy Introduction
11.6.4 Novartis Revenue in Viral Gene Therapy Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 Amgen
11.7.1 Amgen Company Detail
11.7.2 Amgen Business Overview
11.7.3 Amgen Viral Gene Therapy Introduction
11.7.4 Amgen Revenue in Viral Gene Therapy Business (2018-2024)
11.7.5 Amgen Recent Development
11.8 Ionis Pharmaceuticals
11.8.1 Ionis Pharmaceuticals Company Detail
11.8.2 Ionis Pharmaceuticals Business Overview
11.8.3 Ionis Pharmaceuticals Viral Gene Therapy Introduction
11.8.4 Ionis Pharmaceuticals Revenue in Viral Gene Therapy Business (2018-2024)
11.8.5 Ionis Pharmaceuticals Recent Development
11.9 Spark Therapeutics
11.9.1 Spark Therapeutics Company Detail
11.9.2 Spark Therapeutics Business Overview
11.9.3 Spark Therapeutics Viral Gene Therapy Introduction
11.9.4 Spark Therapeutics Revenue in Viral Gene Therapy Business (2018-2024)
11.9.5 Spark Therapeutics Recent Development
11.10 Shanghai Sunway Biotech
11.10.1 Shanghai Sunway Biotech Company Detail
11.10.2 Shanghai Sunway Biotech Business Overview
11.10.3 Shanghai Sunway Biotech Viral Gene Therapy Introduction
11.10.4 Shanghai Sunway Biotech Revenue in Viral Gene Therapy Business (2018-2024)
11.10.5 Shanghai Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Viral Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Viral Gene Therapy Business (2018-2024)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Viral Gene Therapy Introduction
11.12.4 AnGes Revenue in Viral Gene Therapy Business (2018-2024)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Viral Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Viral Gene Therapy Business (2018-2024)
11.13.5 Orchard Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Viral Gene Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Integrating Viral Vectors
Table 3. Key Players of Non-Integrating Viral Vectors
Table 4. Global Viral Gene Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Viral Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Viral Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Viral Gene Therapy Market Share by Region (2018-2024)
Table 8. Global Viral Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Viral Gene Therapy Market Share by Region (2024-2029)
Table 10. Viral Gene Therapy Market Trends
Table 11. Viral Gene Therapy Market Drivers
Table 12. Viral Gene Therapy Market Challenges
Table 13. Viral Gene Therapy Market Restraints
Table 14. Global Viral Gene Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Viral Gene Therapy Market Share by Players (2018-2024)
Table 16. Global Top Viral Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
Table 17. Ranking of Global Top Viral Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Viral Gene Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Viral Gene Therapy Product Solution and Service
Table 21. Date of Enter into Viral Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Viral Gene Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Viral Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Viral Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Viral Gene Therapy Revenue Market Share by Application (2018-2024)
Table 29. Global Viral Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Viral Gene Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Viral Gene Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Viral Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Viral Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Viral Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Lonza Company Detail
Table 47. Lonza Business Overview
Table 48. Lonza Viral Gene Therapy Product
Table 49. Lonza Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Biogen Company Detail
Table 52. Biogen Business Overview
Table 53. Biogen Viral Gene Therapy Product
Table 54. Biogen Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 55. Biogen Recent Development
Table 56. Catalent Company Detail
Table 57. Catalent Business Overview
Table 58. Catalent Viral Gene Therapy Product
Table 59. Catalent Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 60. Catalent Recent Development
Table 61. Gilead Sciences Company Detail
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Viral Gene Therapy Product
Table 64. Gilead Sciences Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Sarepta Therapeutics Company Detail
Table 67. Sarepta Therapeutics Business Overview
Table 68. Sarepta Therapeutics Viral Gene Therapy Product
Table 69. Sarepta Therapeutics Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 70. Sarepta Therapeutics Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Viral Gene Therapy Product
Table 74. Novartis Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Amgen Company Detail
Table 77. Amgen Business Overview
Table 78. Amgen Viral Gene Therapy Product
Table 79. Amgen Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. Ionis Pharmaceuticals Company Detail
Table 82. Ionis Pharmaceuticals Business Overview
Table 83. Ionis Pharmaceuticals Viral Gene Therapy Product
Table 84. Ionis Pharmaceuticals Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 85. Ionis Pharmaceuticals Recent Development
Table 86. Spark Therapeutics Company Detail
Table 87. Spark Therapeutics Business Overview
Table 88. Spark Therapeutics Viral Gene Therapy Product
Table 89. Spark Therapeutics Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 90. Spark Therapeutics Recent Development
Table 91. Shanghai Sunway Biotech Company Detail
Table 92. Shanghai Sunway Biotech Business Overview
Table 93. Shanghai Sunway Biotech Viral Gene Therapy Product
Table 94. Shanghai Sunway Biotech Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 95. Shanghai Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Viral Gene Therapy Product
Table 99. SIBIONO Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Viral Gene Therapy Product
Table 104. AnGes Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Viral Gene Therapy Product
Table 109. Orchard Therapeutics Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Gene Therapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Viral Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Integrating Viral Vectors Features
Figure 4. Non-Integrating Viral Vectors Features
Figure 5. Global Viral Gene Therapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Viral Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Metabolic Diseases Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Muscular Diseases Case Studies
Figure 10. Hematologic Diseases Case Studies
Figure 11. Ophthalmologic Diseases Case Studies
Figure 12. Infectious Diseases Case Studies
Figure 13. Others Case Studies
Figure 14. Viral Gene Therapy Report Years Considered
Figure 15. Global Viral Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Viral Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Viral Gene Therapy Market Share by Region: 2022 VS 2029
Figure 18. Global Viral Gene Therapy Market Share by Players in 2022
Figure 19. Global Top Viral Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Viral Gene Therapy Revenue in 2022
Figure 21. North America Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Viral Gene Therapy Market Share by Country (2018-2029)
Figure 23. United States Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Viral Gene Therapy Market Share by Country (2018-2029)
Figure 27. Germany Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Viral Gene Therapy Market Share by Region (2018-2029)
Figure 35. China Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Viral Gene Therapy Market Share by Country (2018-2029)
Figure 43. Mexico Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Viral Gene Therapy Market Share by Country (2018-2029)
Figure 47. Turkey Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Lonza Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 50. Biogen Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 51. Catalent Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 52. Gilead Sciences Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 53. Sarepta Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 54. Novartis Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 55. Amgen Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 56. Ionis Pharmaceuticals Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 57. Spark Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 58. Shanghai Sunway Biotech Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 59. SIBIONO Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 60. AnGes Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 61. Orchard Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed